Primary Tumor Location Is a Prognostic Factor for Intrahepatic Progression-Free Survival in Patients with Colorectal Liver Metastases Undergoing Portal Vein Embolization as Preparation for Major Hepatic Surgery
The aim of this study was to identify prognostic factors affecting intrahepatic progression-free survival (ihPFS) and overall survival (OS) in patients with colorectal cancer liver metastases (CRCLM) undergoing portal vein embolization (PVE) and subsequent (extended) right hemihepatectomy. A total o...
Main Authors: | Lea Hitpass, Daniel Heise, Maximilian Schulze-Hagen, Federico Pedersoli, Florian Ulmer, Iakovos Amygdalos, Peter Isfort, Ulf Neumann, Christiane Kuhl, Philipp Bruners, Markus Zimmermann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/6/1638 |
Similar Items
-
MRI-Based Quantitation of Hepatic Steatosis Does Not Predict Hypertrophy Rate after Portal Vein Embolization in Patients with Colorectal Liver Metastasis and Normal to Moderately Elevated Fat Fraction
by: Lea Hitpass, et al.
Published: (2021-05-01) -
Hepatic hypertrophy and hemodynamics of portal venous flow after percutaneous transhepatic portal embolization
by: Shingo Shimada, et al.
Published: (2019-02-01) -
Transsplenic portal vein reconstruction–transjugular intrahepatic portosystemic shunt in a patient with portal and splenic vein thrombosis
by: Jason T. Salsamendi, MD, et al.
Published: (2016-09-01) -
Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma
by: Toru Beppu, et al.
Published: (2021-05-01) -
Portale und Ontologien
by: Zimmermann, Kerstin
Published: (2005)